Vienna:RDSM | Jotup

DSM provides Q1 2023 trading update

Retrieved on:

Tuesday, May 2, 2023

Growth, DSM, Nutrition, 2012 Six-red World Championship, Vitamin A, Health, Beauty, Environment, APM, Continuous operation, Anti-corporate activism, Euronext Amsterdam, Fine chemical, Pharmaceutical industry

HEERLEN, Netherlands, May 2, 2023 /PRNewswire/ --

Key Points:

1 Continuing Operations reflects the results of DSM's Health, Nutrition & Bioscience and Corporate Activities as of 1 January 2022.
Organic sales growth is the total impact of volume and price/mix.
Looking to the future, we are very pleased at the overwhelmingly positive response to the exchange of DSM shares for DSM-Firmenich shares.
With the imminent completion of the merger, once DSM and Firmenich's activities have been consolidated and the combined business plan approved by the DSM-Firmenich Board, it is intended that DSM-Firmenich will provide an outlook for the remainder of 2023 at the publication of its Half Year results on 2 August 2023.

FINAL RESULTS OF THE EXCHANGE OFFER: 96.1% OF DSM ORDINARY SHARES TENDERED

Retrieved on:

Monday, May 1, 2023

KAISERAUGST, Switzerland and HEERLEN, Netherlands and GENEVA, May 1, 2023 /PRNewswire/ --

Key Points:

DSM Shareholders who have validly tendered (or defectively tendered, provided that such defect has been waived by the Company) and transferred (geleverd) their DSM Ordinary Shares for acceptance in the Exchange Offer during the Post-Acceptance Period, will receive the Offer Consideration in respect of each tendered DSM Ordinary Share on 3 May 2023 (the Post-Closing Acceptance Settlement Date).
The Company accepts all DSM Ordinary Shares that have been validly tendered (or defectively tendered, provided that such defect has been waived by the Company) pursuant to the terms of the Exchange Offer.
In addition, DSM will procure the termination of the listing and trading of DSM Ordinary Shares on Euronext Amsterdam as soon as practicable.
If a beneficiary to DSM Ordinary Shares located in the United States is unable to make the QIB Confirmations on behalf of itself or the person on whose behalf such DSM Ordinary Shares are held, any DSM-Firmenich Ordinary Shares allotted to such person will instead be transferred to a sales agent, and such DSM-Firmenich Ordinary Shares will be sold on his, her or its behalf with the proceeds being remitted to such person within five days of the Settlement Date, for DSM-Firmenich Ordinary Shares allotted in exchange for DSM Ordinary Shares tendered during the Acceptance Period, or within five days of the Post-Closing Acceptance Settlement Date, for DSM-Firmenich Ordinary Shares allotted in exchange for DSM Ordinary Shares tendered during any Post-Closing Acceptance Period.

DSM - delivery of shares

Retrieved on:

Friday, April 28, 2023

Section 17 of the Constitution Act, 1867, Exercise, DSM, Nutrition, File, Settlement date, Section 13, Exchange, Business analyst, DSM (company), Settlement, Animal, Euronext Amsterdam, Offering circular, Principal, Exchange offer, Security (finance), Health

HEERLEN, Netherlands, April 28, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 28 April 2023 delivered 2,880 DSM-Firmenich ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (average exercise price € 61.89).
At the date hereof, DSM holds a total of 621,433 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4122% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Wednesday, April 26, 2023

HEERLEN, Netherlands, April 26, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 26 April 2023 delivered 15,765 DSM-Firmenich ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (average exercise price €52.73).
At the date hereof, DSM holds a total of 624,313 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4142% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Tuesday, April 25, 2023

HEERLEN, Netherlands, April 25, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
As a result, DSM held a total of 640,228 (instead of 635,176) DSM-Firmenich ordinary shares on 24 April 2023.
At the date hereof, DSM holds a total of 640,078 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4246% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Monday, April 24, 2023

HEERLEN, Netherlands, April 24, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 24 April 2023 delivered 14,139 DSM-Firmenich ordinary shares to employees in view of (i) settling the vesting of 8,474 share units granted under the respective DSM Incentive Plan and (ii) settling the exercise of 5,665 stock options granted under the respective DSM Incentive Plan (average exercise price €61.92).
At the date hereof, DSM holds a total of 635,176 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4214% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Friday, April 21, 2023

Section 17 of the Constitution Act, 1867, Exercise, DSM, Nutrition, File, Settlement date, Section 13, Exchange, Business analyst, Settlement, Animal, Offering circular, Principal, Exchange offer, Security (finance), Health

HEERLEN, Netherlands, April 21, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM Ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
Upon Settlement, DSM received 662,616 DSM-Firmenich Ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 21 April 2023 delivered 825 DSM-Firmenich ordinary shares to employees in view of settling the exercise of 825 stock options granted under the respective DSM Incentive Plan (average exercise price €87.13).
At the date hereof, DSM holds a total of 649,315 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.4307% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Thursday, April 20, 2023

Section 17 of the Constitution Act, 1867, Exercise, DSM, Nutrition, File, Settlement date, Section 13, Exchange, Business analyst, DSM (company), Animal, Euronext Amsterdam, Offering circular, Principal, Exchange offer, Security (finance), Health

HEERLEN, Netherlands, April 20, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

With reference to the Offering Circular (in particular sections 11.16 (Long-term incentive plans) and 13.7 (Principal terms of the Business Combination Agreement)), DSM has during the Acceptance Period tendered in the Exchange Offer 662,616 DSM Ordinary Shares held in treasury in order to be able to fulfill its obligations under the respective DSM Incentive Plans after the Settlement Date.
As a result of the Settlement that took place today, DSM received 662,616 DSM-Firmenich ordinary shares in exchange for the aforementioned DSM Ordinary Shares tendered in the Exchange Offer.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM has on 20 April 2023 delivered 4,680 DSM-Firmenich ordinary shares to employees in view of settling the exercise of 4,680 stock options granted under the respective DSM Incentive Plan (average exercise price €58.16).
At the date hereof, DSM holds a total of 650,140 DSM-Firmenich ordinary shares (in order to be able to fulfill its obligations under the respective DSM Incentive Plans), representing approximately 0.43% of the DSM-Firmenich ordinary shares.

DSM - delivery of shares

Retrieved on:

Wednesday, April 19, 2023

Exercise, DSM, Nutrition, File, Section 13, Exchange, DSM (company), Animal, Euronext Amsterdam, Offering circular, Exchange offer, Security (finance), Pharmaceutical industry, Health

HEERLEN, Netherlands, April 19, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

Key Points:

This is a press release by Koninklijke DSM N.V. (DSM) in connection with the voluntary public exchange offer by DSM Firmenich AG (DSM-Firmenich) for all the issued and outstanding ordinary shares in the share capital of DSM (the Exchange Offer), pursuant to Section 13, paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft (the Decree).
HEERLEN, Netherlands, April 19, 2023 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.
Pursuant to commitments entered into prior to issuing the Offering Circular, DSM will deliver 7,796 DSM-Firmenich ordinary shares to employees in view of transactions that occurred on 19 April 2023, being: (i) settlement of the vesting of 386 share units that have been granted subject to the respective DSM Incentive Plan and (ii) settlement of the exercise of 7,410 stock options granted under the respective DSM Incentive Plan (average exercise price € 55.03).
Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet.

EXCHANGE OFFER DECLARED UNCONDITIONAL

Retrieved on:

Monday, April 17, 2023

KAISERAUGST, Switzerland and HEERLEN, Netherlands and GENEVA, April 17, 2023 /PRNewswire/ --

Key Points:

After settlement of the Post-Closing Acceptance Period, the Company intends to implement either the Buy-Out or the Post-Offer Merger and Liquidation
DSM and Firmenich boards are very pleased to announce that the Company hereby declares the Exchange Offer unconditional.
As a result, the Exchange Offer will be settled on 20 April 2023 and the Firmenich Contribution will occur on 8 May 2023.
This announcement contains selected, condensed information regarding the Exchange Offer and does not replace the Offering Circular.
Accordingly, to be eligible to receive DSM-Firmenich Ordinary Shares under the Exchange Offer, each DSM Shareholder that is a U.S.